JUL 31, 2026 · PHASE 3 TRIAL
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
ClinicalTrials.gov
This is an active Phase 3 RCT registration with no posted results; the study is recruiting and outcome data are not yet available, making any efficacy claim impossible.
Reported
Planned enrollment3380
Primary outcome measureInvasive breast cancer free survival (IBCFS…
Maximum follow-up duration120 months